Albert Einstein College of Medicine, Department of Emergency Medicine, Rose F. Kennedy Center, 1410 Pelham Parkway South, Bronx, NY 10461, USA.
Montefiore Medical Center, Department of Emergency Medicine, 111 East 210(th) Street, Bronx, NY 10467, USA.
Am J Emerg Med. 2022 Apr;54:274-278. doi: 10.1016/j.ajem.2022.01.070. Epub 2022 Feb 6.
To determine how cohorting patients based on presenting complaints affects risk of nosocomial infection in crowded Emergency Departments (EDs) under conditions of high and low prevalence of COVID-19.
This was a retrospective analysis of presenting complaints and PCR tests collected during the COVID-19 epidemic from 4 EDs from a large hospital system in Bronx County, NY, from May 1, 2020 to April 30, 2021. Sensitivity, specificity, positive and negative predictive value (PPV, NPV) were calculated for a symptom screen based on the CDC list of COVID-19 symptoms: fever/chills, shortness of breath/dyspnea, cough, muscle or body ache, fatigue, headache, loss of taste or smell, sore throat, nasal congestion/runny nose, nausea, vomiting, and diarrhea. PPV was calculated for varying values of prevalence.
There were 80,078 visits with PCR tests. The sensitivity of the symptom screen was 64.7% (95% CI: 63.6, 65.8), specificity 65.4% (65.1, 65.8). PPV was 16.8% (16.5, 17.0) and NPV was 94.5% (94.4, 94.7) when the observed prevalence of COVID-19 in the ED over the year was 9.7%. The PPV of fever/chills, cough, body and muscle aches and nasal congestion/runny nose were each approximately 25% across the year, while diarrhea, nausea, vomiting and headache were less predictive, (PPV 4.7%-9.6%) The combinations of fever/chills, cough, muscle/body aches, and shortness of breath had PPVs of 40-50%. The PPV of the screen varied from 3.7% (3.6, 3.8) at 2% prevalence of COVID-19 to 44.3% (44.0, 44.7) at 30% prevalence.
The proportion of patients with a chief complaint of COVID-19 symptoms and confirmed COVID-19 infection was exceeded by the proportion without actual infection. This was true when prevalence in the ED was as high as 30%. Cohorting of patients based on the CDC's list of COVID-19 symptoms will expose many patients who do not have COVID-19 to risk of nosocomially acquired COVID-19. EDs should not use the CDC list of COVID-19 symptoms as the only strategy to minimize exposure.
确定根据就诊症状对患者进行分组是否会影响高、低 COVID-19 流行率下拥挤的急诊科(ED)院内感染的风险。
这是对 2020 年 5 月 1 日至 2021 年 4 月 30 日期间,来自纽约布朗克斯县一家大型医院系统的 4 个 ED 中 COVID-19 流行期间收集的就诊症状和 PCR 检测进行的回顾性分析。基于疾病预防控制中心列出的 COVID-19 症状(发热/寒战、呼吸急促/呼吸困难、咳嗽、肌肉或身体疼痛、疲劳、头痛、味觉或嗅觉丧失、喉咙痛、鼻塞/流鼻涕、恶心、呕吐和腹泻),计算了症状筛查的灵敏度、特异性、阳性和阴性预测值(PPV、NPV)。对于不同流行率的情况,计算了 PPV。
共进行了 80078 次 PCR 检测。症状筛查的灵敏度为 64.7%(95%CI:63.6,65.8),特异性为 65.4%(65.1,65.8)。当 ED 中 COVID-19 的全年观察流行率为 9.7%时,PPV 为 16.8%(16.5,17.0),NPV 为 94.5%(94.4,94.7)。发热/寒战、咳嗽、身体和肌肉疼痛以及鼻塞/流鼻涕的 PPV 全年均约为 25%,而腹泻、恶心、呕吐和头痛的预测性较低(PPV 为 4.7%-9.6%)。发热/寒战、咳嗽、肌肉/身体疼痛和呼吸急促的组合的 PPV 为 40-50%。该筛查的 PPV 从 2%COVID-19 流行率下的 3.7%(3.6,3.8)到 30%流行率下的 44.3%(44.0,44.7)不等。
有 COVID-19 症状主诉和确诊 COVID-19 感染的患者比例超过了没有实际感染的患者比例。当 ED 中的流行率高达 30%时,情况也是如此。根据疾病预防控制中心列出的 COVID-19 症状对患者进行分组,将使许多没有 COVID-19 的患者面临获得医院获得性 COVID-19 的风险。ED 不应仅使用疾病预防控制中心列出的 COVID-19 症状作为将接触风险最小化的唯一策略。